Clinical Trial Update: TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas [Phase 1]

View source ↗

Summary

A Phase 1 trial of TLN-121 for relapsed or refractory non-Hodgkin lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• TLN-121

Snippet

Sponsor: Treeline Biosciences, Inc. | Conditions: Lymphoma, Lymphoma, Non Hodgkin | Phase 1 | Status: RECRUITING